Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. [electronic resource]
Producer: 20110728Description: 2191-8 p. digitalISSN:- 1527-7755
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Calcitriol -- administration & dosage
- Docetaxel
- Drug Resistance, Neoplasm
- Early Termination of Clinical Trials
- Humans
- Male
- Prednisone -- administration & dosage
- Prostatic Neoplasms -- drug therapy
- Salvage Therapy -- methods
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.